Wells Fargo’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11 Sell
1
-1
-50% -$17 ﹤0.01% 7051
2026
Q1
$31 Buy
+2
New +$38 ﹤0.01% 6701
2025
Q4
Hold
0
7072
2025
Q3
Hold
0
6950
2025
Q2
Hold
0
6974
2025
Q1
Hold
0
6893
2024
Q4
Hold
0
6851
2024
Q3
Hold
0
6687

Other funds holding MRNY

Wells Fargo's MRNY Position: Q2 2026 in Review

Wells Fargo reduced its YieldMax MRNA Option Income Strategy ETF (MRNY) stake by 50% in Q2 2026, selling an estimated $17 and leaving 1 share worth $11. The position accounts for ﹤0.01% of the portfolio, ranked #7051.

Wells Fargo first reported a position in MRNY in Q1 2026 and has held it in 2 quarters since. The position peaked at $31 in Q1 2026. 10 funds tracked by Wall St. Rank hold MRNY as of Q2 2026.

  • Wells Fargo held 1 share of YieldMax MRNA Option Income Strategy ETF worth $11 as of Q2 2026.
  • Wells Fargo sold 1 YieldMax MRNA Option Income Strategy ETF share in Q2 2026, an estimated $17.
  • YieldMax MRNA Option Income Strategy ETF made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #7051 holding.
  • Wells Fargo first reported a position in YieldMax MRNA Option Income Strategy ETF in Q1 2026 and has held it in 2 quarters since.
  • Wells Fargo's YieldMax MRNA Option Income Strategy ETF position peaked at $31 in Q1 2026.
  • 10 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.